Skip to main content
OpenTrials
Completed

NCT Number: NCT03356288

The General Breathing Record Study

This study will test the use of a new handheld device (called the N-Tidal C), that measures a person's tidal breath carbon dioxide, in diagnosing the cause of someone's breathlessness. It will also evaluate whether this device can detect when a person's breathing problem is getting worse.

Completed

Looking for future studies?

Notify Me

Key information

About this study

When a person breathes out, they exhale carbon dioxide (CO2). The CO2 levels in breath change as they breathe out and this makes a specific pattern, or "waveform". This waveform can tell a clinician a lot about the underlying health of a person. There are disease specific CO2 waveforms for common breathing conditions such as Asthma and Chronic Obstructive Pulmonary Disease (COPD). However up until this point there has been no accurate and non-invasive method of measuring the tidal breath CO2 waveform.

This study will test the N-Tidal C, a new handheld device that accurately measures this waveform, and whether it can differentiate different causes of breathlessness; namely asthma, heart failure, pneumonia, breathing pattern disorders and motor neurone disease.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Asthma Cohort:

  • A confirmed clinical diagnosis of asthma for ≥ 6months
  • Moderate to severe asthma defined as British Thoracic Society stages 3-5
  • 2 or more exacerbations in the previous 12 months with at least 1 exacerbation within the last 6 months.
  • Exacerbation free for 2 weeks (defined as no increased dose or course of oral corticosteroids or antibiotics).

Breathing Pattern Disorder Cohort

  • A Clinical diagnosis of a Breathing Pattern Disorder (BPD)

Chronic heart failure Cohort:

  • A confirmed clinical diagnosis of chronic heart failure with both of the following:
  • A Left Ventricular Ejection Fraction <40% on most recent imaging within the last 12 months.
  • New York Heart Association Class 2-4
  • Admitted with an acute decompensation of their heart failure to hospital within the last 6 months

Motor Neurone Disease Cohort:

  • A confirmed clinical diagnosis of Motor Neurone Disease
  • Forced Vital Capacity (FVC) of less than 60% of predicted, sleep disordered breathing or daytime hypercapnia.
  • Established on Home Non-Invasive Ventilation.

Pneumonia Cohort:

  • A confirmed clinical diagnosis of Pneumonia supported by evidence of consolidation on a chest X-ray (CXR) or computed tomography (CT) imaging.

Healthy Cohort:

  • No known history of lung, cardiac or neuromuscular disease (defined as no current clinical diagnosis of, or be receiving treatment for, a lung, cardiac or neuromuscular disease). A Body Mass Index of less than 40. A Non-smoker, or an ex-smoker with less than a 5 pack year history.

Exclusion criteria

  • Known other lung, chest wall, neuromuscular, cardiac or other comorbidity or abnormality that would affect spirometry and/or other measures of lung function or Tidal Breath Carbon Dioxide measurements.
  • In the opinion of the clinical investigator, the participant would have difficulty completing the study procedures consistently over the course of 6 months.

Treatment and study plan

Primary outcomes

  1. The tidal breathing carbon dioxide waveform for each of the breathing conditions as measured by the N-Tidal C device

    Time frame: 12 months

Secondary outcomes

  1. Change in the Tidal Breathing carbon dioxide waveform over time

    Time frame: Change measures - baseline to 6 months

    Change in the tidal breathing carbon dioxide waveform, in each disease, over the 6 months.

  2. Disease Control in asthma patients

    Time frame: 12 months

    The Asthma Control Questionnaire Score for the Asthma patients

  3. Disease Improvement in Breathing Pattern Disorder patients

    Time frame: 12 months

    The Nijmegen Questionnaire Score

  4. Disease severity in the pneumonia patients

    Time frame: 2 days

    The CURB-65 Score

  5. Disease severity in heart failure patients

    Time frame: 12 months

    The Trans Thoracic Echocardiogram (TTE) result

  6. Hypercapnia in the motor neurone disease patients

    Time frame: 12 months

    The level of partial pressure carbon dioxide (pCO2)

  7. Usability of the N-Tidal C device

    Time frame: Change measures - baseline to 6 months

    Measured by how frequently the patients remember to use the N-Tidal C device over 6 months

  8. Acceptability of the N-Tidal C device

    Time frame: 12 months

    Measured by a questionnaire of the participants experience of the device at the end of the study

Sponsors and collaborators

Lead sponsor

TidalSense

Industry

Collaborators

  • Innovate UK

Registry information

Official study title

An Observational Proof-of-concept Study to Explore the Waveform Characteristics of Tidal Breathing Carbon Dioxide (CO2), Measured Using the N-Tidal C™ Device, in Different Breathing Conditions.

Acronym: GBRS

Important dates

Study start
2017
Primary completion
2018
Study completion
2018
First posted
Nov 29, 2017
Registry last updated
Sep 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.